Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021

SELL
$13.6 - $17.88 $8.76 Million - $11.5 Million
-644,273 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$16.0 - $20.59 $2.04 Million - $2.62 Million
-127,320 Reduced 16.5%
644,273 $10.5 Million
Q1 2021

May 12, 2021

SELL
$19.16 - $28.09 $171,941 - $252,079
-8,974 Reduced 1.15%
771,593 $15.5 Million
Q3 2020

Nov 16, 2020

BUY
$14.05 - $18.13 $2.91 Million - $3.75 Million
207,011 Added 36.09%
780,567 $13.8 Million
Q2 2020

Aug 14, 2020

BUY
$9.41 - $16.94 $294,533 - $530,222
31,300 Added 5.77%
573,556 $9.72 Million
Q1 2020

May 15, 2020

BUY
$6.88 - $19.7 $3.73 Million - $10.7 Million
542,256 New
542,256 $5.28 Million

Others Institutions Holding PROF

About Profound Medical Corp.


  • Ticker PROF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 20,851,300
  • Market Cap $165M
  • Description
  • Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for...
More about PROF
Track This Portfolio

Track Pura Vida Investments, LLC Portfolio

Follow Pura Vida Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pura Vida Investments, LLC with notifications on news.